ZA93811B - Methods of treating inflammatory dermatoses. - Google Patents

Methods of treating inflammatory dermatoses.

Info

Publication number
ZA93811B
ZA93811B ZA93811A ZA93811A ZA93811B ZA 93811 B ZA93811 B ZA 93811B ZA 93811 A ZA93811 A ZA 93811A ZA 93811 A ZA93811 A ZA 93811A ZA 93811 B ZA93811 B ZA 93811B
Authority
ZA
South Africa
Prior art keywords
methods
treating inflammatory
inflammatory dermatoses
dermatoses
treating
Prior art date
Application number
ZA93811A
Other languages
English (en)
Inventor
Albert M Kligman
Original Assignee
Albert M Kligman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Albert M Kligman filed Critical Albert M Kligman
Publication of ZA93811B publication Critical patent/ZA93811B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA93811A 1992-02-07 1993-02-05 Methods of treating inflammatory dermatoses. ZA93811B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US83282892A 1992-02-07 1992-02-07

Publications (1)

Publication Number Publication Date
ZA93811B true ZA93811B (en) 1993-09-10

Family

ID=25262717

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA93811A ZA93811B (en) 1992-02-07 1993-02-05 Methods of treating inflammatory dermatoses.

Country Status (12)

Country Link
US (1) US5998395A (xx)
EP (1) EP0625045A4 (xx)
JP (1) JP2927961B2 (xx)
KR (1) KR100282575B1 (xx)
AU (1) AU667519B2 (xx)
CA (1) CA2129114A1 (xx)
CZ (1) CZ188394A3 (xx)
FI (1) FI943625A (xx)
NO (1) NO942913L (xx)
NZ (1) NZ249379A (xx)
WO (1) WO1993015740A1 (xx)
ZA (1) ZA93811B (xx)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0659080B1 (en) * 1992-09-11 2001-07-11 BROWN, Sandra Method for the treatment of hair loss
US6344448B1 (en) 1992-09-11 2002-02-05 Stb Family Limited Partnership Composition for the treatment of hair loss
US7115728B1 (en) 1995-01-30 2006-10-03 Ligand Pharmaceutical Incorporated Human peroxisome proliferator activated receptor γ
AU5728596A (en) * 1995-05-05 1996-11-21 Mark S. Braiman Treatment of psoriasis with 11-cis-retinoic acid
US6008254A (en) * 1997-05-09 1999-12-28 Kligman; Douglas E. Method of treating skin disorders with high-strength tretinoin
AU8588798A (en) 1997-07-25 1999-02-16 Institut Pasteur Human peroxisome proliferator activated receptor gamma (ppargamma) gene re gulatory sequences and uses therefor
US8541469B2 (en) * 1997-08-23 2013-09-24 Glaxo Group Limited Treatment of cell-mediated immune diseases
EP1025857A4 (en) * 1997-10-22 2003-11-12 Eisai Co Ltd RETINOIC ACID AGONISTS, PREVENTIVE AND THERAPEUTIC AGENTS FOR NEPHRITES
FR2761600B1 (fr) 1998-06-19 2000-03-31 Oreal Composition moussante pour le lavage et le traitement des cheveux et/ou du cuir chevelu a base d'un principe actif, d'un tensioactif anionique, d'un tensioactif amphotere et d'un agent propenetrant
US6242473B1 (en) * 1999-01-08 2001-06-05 Maxim Pharmaceuticals, Inc. Treatment and prevention of reactive oxygen metabolite-mediated cellular damage
FR2804323B1 (fr) * 2000-01-31 2006-07-07 Galderma Res & Dev Utilisation de composes de type retinoides en tant qu'agents anti-bacteriens
US6440465B1 (en) * 2000-05-01 2002-08-27 Bioderm, Inc. Topical composition for the treatment of psoriasis and related skin disorders
US20050003023A1 (en) * 2002-06-28 2005-01-06 Meisner Lorraine Faxon Topical composition for the treatment of psoriasis and related skin disorders
ATE402692T1 (de) * 2000-05-09 2008-08-15 Kaneka Corp Dermale zusammenstellungen die als wirkstoff coenzym q enthalten
AU2001290816A1 (en) 2000-09-13 2002-03-26 Bristol-Myers Squibb Company Retinoic acid receptor antagonists as promoters of angiogenesis
KR20020027198A (ko) * 2000-10-02 2002-04-13 차알스 제이. 메츠 염증과 홍반의 완화방법
FR2823117A1 (fr) * 2000-11-14 2002-10-11 Pharmascience Lab Composition pharmaceutique ou cosmetique ainsi que l'utilisation d'au moins un compose actif pour inhiber la migration des cellules de langerhans
WO2002071025A2 (en) * 2001-03-02 2002-09-12 Spectra Systems Corporation Combinatorial chemistry and compound identification system
ES2188426B1 (es) * 2001-12-12 2004-11-16 Rosalia Pidal Fernandez Composicion farmaceutica para el tratamiento de la psoriasis y otras dermopatias.
US20030199488A1 (en) * 2002-04-23 2003-10-23 Trotta Gina M. Treatment of hyperproliferative disorders/inflammatory dermatoses
US6723755B2 (en) 2002-06-12 2004-04-20 Piotr Chomczynski Method of treating rosacea
US20040171561A1 (en) * 2002-09-03 2004-09-02 Popp Karl F. Topical formulations for treatment of rosacea
US8232304B2 (en) * 2002-10-24 2012-07-31 G & R Pharmaceuticals, Llc Antifungal formulations
US20050095215A1 (en) * 2003-11-03 2005-05-05 Popp Karl F. Antimicrobial shampoo compositions
ATE497763T1 (de) * 2003-11-21 2011-02-15 Zalicus Inc Verfahren und reagenzien zur behandlung von entzündlichen erkrankungen
NZ549159A (en) * 2004-02-19 2011-01-28 Chemaphor Inc Topical formulations for the treatment of skin conditions
US7812057B2 (en) * 2004-08-25 2010-10-12 Molecular Research Center, Inc. Cosmetic compositions
KR101327590B1 (ko) 2004-09-28 2013-11-12 체마폴, 인코포레이티드. 체중 증가 및 사료 전환을 촉진하는 조성물 및 방법
US20070009607A1 (en) * 2005-07-11 2007-01-11 George Jones Antibacterial/anti-infalmmatory composition and method
AU2008316225B2 (en) 2007-10-26 2014-06-19 Avivagen Inc. Compositions and methods for enhancing immune response
ES2327201B1 (es) 2008-04-23 2010-07-23 Ignacio Umbert Millet Composicion farmaceutica personalizada para el rejuvenecimiento de la piel que contiene acido retinoico.
CA2975313C (en) 2009-04-30 2020-06-30 Avivagen Inc. Methods and compositions for improving the health of animals
EP2490542A4 (en) 2009-10-20 2015-12-30 Discovery Partners Llc DERMATOLOGICAL AND COSMETIC COMPOSITIONS
ES2378028B1 (es) 2012-02-22 2013-02-18 Ignacio Umbert Millet Composición cosmética para el rejuvenecimiento de la piel y procedimiento y usos correspondientes
KR20200060459A (ko) * 2017-09-28 2020-05-29 존슨 앤드 존슨 컨수머 인코포레이티드 화장 조성물 및 피부 치료 방법
RU2712281C1 (ru) * 2018-11-23 2020-01-28 Общество С Ограниченной Ответственностью "Хемиммьюн Терапьютикс" Применение производного глутаримида для преодоления резистентности к стероидам и терапии заболеваний, ассоциированных с аберрантным сигналингом интерферона гамма

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3729568A (en) * 1969-09-23 1973-04-24 Johnson & Johnson Acne treatment
US4126693A (en) * 1975-11-03 1978-11-21 Johnson & Johnson Retinoic acid derivatives in the treatment of acne
ZA77678B (en) * 1977-02-07 1978-09-27 S Fourie Pharmaceutical composition and use thereof
US4487782A (en) * 1982-03-26 1984-12-11 Ortho Pharmaceutical Corporation Topical treatment of non-inflammatory acne
US4889847A (en) * 1986-11-03 1989-12-26 Ortho Pharmaceutical Corporation Prevention of glucocorticoid-induced skin atrophy
US5019569A (en) * 1986-11-03 1991-05-28 Ortho Pharmaceutical Corporation Reversal of glucocorticoid-induced skin atrophy

Also Published As

Publication number Publication date
EP0625045A4 (en) 1995-01-18
NO942913D0 (xx) 1994-08-05
AU3585493A (en) 1993-09-03
NZ249379A (en) 1998-07-28
KR100282575B1 (ko) 2001-02-15
CZ188394A3 (en) 1996-02-14
WO1993015740A1 (en) 1993-08-19
FI943625A0 (fi) 1994-08-04
JPH07505617A (ja) 1995-06-22
US5998395A (en) 1999-12-07
AU667519B2 (en) 1996-03-28
CA2129114A1 (en) 1993-08-19
KR950700069A (ko) 1995-01-16
EP0625045A1 (en) 1994-11-23
FI943625A (fi) 1994-08-04
NO942913L (no) 1994-10-05
JP2927961B2 (ja) 1999-07-28

Similar Documents

Publication Publication Date Title
ZA93811B (en) Methods of treating inflammatory dermatoses.
GR3036347T3 (en) Compounds useful for treating allergic and inflammatory diseases.
EP0634930A4 (en) Compounds useful for treating allergic and inflammatory diseases.
EP0576178A3 (en) Method for maintaining the relationships between elements.
ZA945657B (en) Method to inhibit restenosis
EP0604804A3 (de) Isolierband und Verfahren zu seiner Herstellung.
IL105441A0 (en) System for treating buildings
EP0814814A4 (en) METHODS OF TREATING THROMBOSIS
GB2265399B (en) Horizontal well treatment method
EP0661124A3 (en) Process for processing composite materials.
KR0166397B1 (ko) 트랜지스터 및 그 제조방법
EP0673384A4 (en) POLYPEPTIDES USEFUL IN TREATING INFLAMMABLE DISEASES.
PL334012A1 (en) Novel method of treating the arthritis
EP0579453A3 (en) Composition for masonry treatment and process.
EP0630383A4 (en) METHODS OF TREATING DIABETES.
EP0674707A4 (en) COMPOUNDS AND METHODS FOR THE TREATMENT OF LEUCOMA.
ZA933151B (en) Cycloheptimidazole derivatives, method of manufacturing the same and therapeutic agents containing these compounds.
EP0571352A3 (en) Process for processing composite materials.
ZA965346B (en) Methods of treating neuropeptide Y-associated conditions.
GB9205600D0 (en) Disinfecting method
EP0589347A3 (en) Switch and method for controlling this switch.
EP0584795A3 (en) Electronic development agent and its manufacturing process.
EP0654996A4 (en) METHOD FOR TREATING PSORIASIS USING SUBSTITUTED AZASPIRANS.
EP0588556A3 (en) Treatment of maltodextrins.
EP0624089A4 (en) Methods.